22 Aug 2013
(MENAFN) Hikma, Jordanian pharmaceutical company, decided to raise its estimated revenue for 2013 on the back of an impressive revenue growth in the first half, The National reported.
The firm”s revenue in the first half hit USD638.3 million registering a 20 percent boost compared to first half of 2012. Revenue from the Middle East and North Africa (Mena) region jumped by 46 percent
The pharmaceutical maker, whose products are sold in the Mena region, Europe and the US, expects revenue for the entire year to increase by 20 percent.
This jump in revenue is due to strong sales of the antibiotic doxycycline. Generic drug revenue is estimated to hit USD230 million in 2013 after reaching USD132 million in the first half, registering a 136.6 percent increase.
13 Apr 2026
BBK launches the Youth Advisory Council (YAC) to empower youth and advance innovation
08 Apr 2026
BBK awards over BD 1 Million to 273 winners in the February Al Hayrat Grand Prizes draw
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more